Bayer Agreement | Bullish channel

Bayer, a pharmaceutical group, announced that it has agreed to pay 10.1 - 10.9 billion dollars to resolve major outstanding Monsanto litigation

Charts (6)

Bayer, a pharmaceutical group, announced that it has agreed to pay 10.1 - 10.9 billion dollars to resolve major outstanding Monsanto litigation, including U.S. Roundup product liability litigation, dicamba drift litigation and PCB water litigation. The company said: "The main feature is the U.S. Roundup resolution that will bring closure to approximately 75% of the current Roundup litigation involving approximately 125,000 filed and unfiled claims overall."


From a chartist’s point of view, the stock price is nearing the upper end of a short term bullish channel. The daily Relative Strength Index (RSI, 14) struck against its overbought area at 70% and is posting a consolidation move. The 20/50DMAs are ascending and should play a support role. The configuration is mixed. Investors have to remain cautious as these levels may trigger profit taking. Pullbacks to 65E can occur before prices can resume their up trend.  A break above 73.5E would open a path to see 78E. Alternatively, a break below 60E would invalidate the short term bullish bias.

Source: GAIN Capital, TradingView

Build your confidence risk free

More from Equities

Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.